Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jun;2(6):e61.
doi: 10.1371/journal.ppat.0020061. Epub 2006 Jun 16.

Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis

Affiliations

Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis

Sebastian Gagneux et al. PLoS Pathog. 2006 Jun.

Abstract

Understanding the ecology of drug-resistant pathogens is essential for devising rational programs to preserve the effective lifespan of antimicrobial agents and to abrogate epidemics of drug-resistant organisms. Mathematical models predict that strain fitness is an important determinant of multidrug-resistant Mycobacterium tuberculosis transmission, but the effects of strain diversity have been largely overlooked. Here we compared the impact of resistance mutations on the transmission of isoniazid-resistant M. tuberculosis in San Francisco during a 9-y period. Strains with a KatG S315T or inhA promoter mutation were more likely to spread than strains with other mutations. The impact of these mutations on the transmission of isoniazid-resistant strains was comparable to the effect of other clinical determinants of transmission. Associations were apparent between specific drug resistance mutations and the main M. tuberculosis lineages. Our results show that in addition to host and environmental factors, strain genetic diversity can influence the transmission dynamics of drug-resistant bacteria.

PubMed Disclaimer

Conflict of interest statement

Competing interests. The authors have declared that no competing interests exist.

References

    1. World Health Organization. Geneva: World Health Organization; 2004. Report Number HO/HTM/TB/2004.343.
    1. Blower SM, Chou T. Modeling the emergence of the “hot zones”: Tuberculosis and the amplification dynamics of drug resistance. Nat Med. 2004;10:1111–1116. - PubMed
    1. Cohen T, Murray M. Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness. Nat Med. 2004;10:1117–1121. - PMC - PubMed
    1. Dye C, Espinal MA, Watt CJ, Mbiaga C, Williams BG. Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis. 2002;185:1197–1202. - PubMed
    1. DeRiemer K, Garcia-Garcia L, Bobadilla-del-Valle M, Palacios-Martinez M, Martinez-Gamboa A, et al. Does DOTS work in populations with drug-resistant tuberculosis? Lancet. 2005;365:1239–1245. - PubMed

Publication types

MeSH terms